BAD: Pause in Oxford vaccine, inexplicable disease participants

The first clinical trials for the coronary vaccine, conducted by AstraZeneca and Oxford University, have been suspended after a participant is allegedly ill. AstraZeneca described it as a pause “ruin” in the case of an unex2 inexplicable disease. ” The results of the vaccine are being considered very carefully worldwide, writes the BBC, translates Periscope. [...]
AstraZeneca described it as a pause “ruin” in the case of an unex2 inexplicable disease. ”
The results of the vaccine are being seen very carefully worldwide, Writes BBC, translates Periscope.
This vaccine is seen as a very strong racer among the ten that are developing globally.
Hopes were high that the vaccine could be the first to hit the market, after stages 1 and 2 that resulted in success.
The transition in the third phase of tests occurred last week and included about 30,000 participants in the US, Britain, Brazil and South Africa. /Periscope












